Patoloxía Molecular das Doenzas Raras
PatMol-DR
![Foto de Patoloxía Molecular das Doenzas Raras](/img/grupo.png)
![Foto de French Institute of Health and Medical Research](/img/noimage_org.png)
French Institute of Health and Medical Research
París, FranciaPublicacións en colaboración con investigadores/as de French Institute of Health and Medical Research (7)
2022
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
2020
-
European lipodystrophy registry: Background and structure
Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1
2018
-
Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification
Atherosclerosis, Vol. 278, pp. 124-134
2017
-
Clinical Utility Gene Card for: Familial partial lipodystrophy
European Journal of Human Genetics, Vol. 25, Núm. 2
2004
-
GH prevents apostosis in cardiomyocytes cultured in vitro through a calcineurin-dependent mechanism
Journal of Endocrinology, Vol. 180, Núm. 2, pp. 325-335